ADICET BIO INC's ticker is ACET and the CUSIP is 007002108. A total of 104 filers reported holding ADICET BIO INC in Q2 2022. The put-call ratio across all filers is 0.53 and the average weighting 0.4%.
Links
Filings
- All filings
- Annual reports (10-K)
- Quarterly reports (10-Q)
- Insider transactions
- Shareholder votes
- Significant ownership
- Events
EDGAR links
External links
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $5,255,836 | -11.6% | 3,836,377 | +56.7% | 0.00% | 0.0% |
| Q2 2023 | $5,948,259 | -37.0% | 2,447,843 | +49.3% | 0.00% | 0.0% |
| Q1 2023 | $9,445,698 | -35.3% | 1,639,878 | +0.5% | 0.00% | -50.0% |
| Q4 2022 | $14,590,564 | -38.2% | 1,632,054 | -1.7% | 0.00% | -33.3% |
| Q3 2022 | $23,616,000 | -1.0% | 1,660,677 | +1.6% | 0.00% | 0.0% |
| Q2 2022 | $23,853,000 | +7877.6% | 1,633,737 | +10823.6% | 0.00% | – |
| Q1 2022 | $299,000 | +19.6% | 14,956 | +4.3% | 0.00% | – |
| Q4 2021 | $250,000 | +103.3% | 14,335 | -8.0% | 0.00% | – |
| Q3 2021 | $123,000 | -20.1% | 15,578 | +4.3% | 0.00% | – |
| Q2 2021 | $154,000 | +2466.7% | 14,932 | +3037.0% | 0.00% | – |
| Q1 2021 | $6,000 | -97.3% | 476 | -97.0% | 0.00% | – |
| Q4 2020 | $222,000 | +93.0% | 15,791 | +63.3% | 0.00% | – |
| Q3 2020 | $115,000 | – | 9,670 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| JOHNSON & JOHNSON | 728,944 | $998,653 | 0.37% |
| DAFNA Capital Management LLC | 797,054 | $1,091,964 | 0.34% |
| COWEN AND COMPANY, LLC | 2,715,278 | $3,719,930 | 0.26% |
| Orbimed Advisors | 8,322,140 | $11,401,332 | 0.24% |
| TANG CAPITAL MANAGEMENT LLC | 1,226,352 | $1,680,102 | 0.24% |
| Carlyle Group Inc. | 2,115,385 | $2,876,924 | 0.12% |
| RTW INVESTMENTS, LP | 4,241,472 | $5,810,817 | 0.12% |
| Acuitas Investments, LLC | 136,779 | $187,387 | 0.11% |
| Decheng Capital Management III (Cayman), LLC | 200,201 | $274,275 | 0.09% |
| GSA CAPITAL PARTNERS LLP | 142,168 | $195 | 0.02% |